Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microalbuminuria.

J Segura1, L M Ruilope, J L Rodicio

  • 1Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relating the Canadian and Japanese beef grading sites.

Meat science·2025
Same author

Refractory arterial hypertension. What can we offer these patients?

Hipertension y riesgo vascular·2025
Same author

Effects of in-the-bag dry-ageing on meat quality, palatability and volatile compounds of low-value beef cuts.

Meat science·2023
Same author

[2022 Practice guidelines for the management of arterial hypertension of the Spanish Society of Hypertension].

Hipertension y riesgo vascular·2022
Same author

BIPSPI+: Mining Type-Specific Datasets of Protein Complexes to Improve Protein Binding Site Prediction.

Journal of molecular biology·2022
Same author

Effect of in-the-bag dry-ageing on meat palatability and volatile compounds of cull cows and youthful steers.

Meat science·2022

Microalbuminuria detection is crucial for predicting cardiovascular and renal risk in hypertensive patients. Early identification aids in selecting targeted therapies to prevent adverse cardiovascular events.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Microalbuminuria is a known predictor of cardiovascular and renal risk in diabetic, hypertensive, and general populations.
  • Approximately 40% of essential hypertension patients exhibit microalbuminuria, especially those with uncontrolled blood pressure.
  • Albuminuria serves as a marker for renal damage and cardiovascular risk in essential hypertension.

Purpose of the Study:

  • To evaluate the relevance of microalbuminuria detection in essential hypertension for selecting therapeutic strategies.
  • To assess microalbuminuria as a tool for defining cardiovascular risk profiles and stratifying prognosis in hypertensive patients.
  • To explore the role of ACE-inhibitors and angiotensin II receptor antagonists in managing microalbuminuria.

Main Methods:

Related Experiment Videos

  • Observational analysis of microalbuminuria prevalence in essential hypertension.
  • Assessment of microalbuminuria as a prognostic marker for renal and cardiovascular risk.
  • Review of therapeutic interventions, including ACE-inhibitors and ARBs, for microalbuminuria reduction.

Main Results:

  • Microalbuminuria is prevalent in uncontrolled essential hypertension, indicating increased risk.
  • Microalbuminuria effectively stratifies prognosis related to renal and cardiovascular outcomes.
  • ACE-inhibitors and ARBs demonstrate efficacy in reducing microalbuminuria.

Conclusions:

  • Microalbuminuria is a valuable, simple method for cardiovascular risk stratification in hypertensive patients.
  • Routine determination of microalbuminuria can guide therapeutic choices for essential hypertension.
  • Targeted therapies like ACE-inhibitors and ARBs are effective in managing microalbuminuria and associated risks.